Cargando…
Correction to: MicroRNA-125b reverses oxaliplatin resistance in hepatocellular carcinoma by negatively regulating EVA1A mediated autophagy
Autores principales: | Ren, Wei-Wei, Li, Dan-Dan, Chen, Xiaolan, Li, Xiao-Long, He, Ya-Ping, Guo, Le-Hang, Liu, Lin-Na, Sun, Li-Ping, Zhang, Xiao-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109171/ https://www.ncbi.nlm.nih.gov/pubmed/30143606 http://dx.doi.org/10.1038/s41419-018-0836-y |
Ejemplares similares
-
MicroRNA-125b reverses oxaliplatin resistance in hepatocellular carcinoma by negatively regulating EVA1A mediated autophagy
por: Ren, Wei-Wei, et al.
Publicado: (2018) -
Integrin β4 promotes cell invasion and epithelial-mesenchymal transition through the modulation of Slug expression in hepatocellular carcinoma
por: Li, Xiao-Long, et al.
Publicado: (2017) -
Author Correction: Integrin β4 promotes cell invasion and epithelial-mesenchymal transition through the modulation of Slug expression in hepatocellular carcinoma
por: Li, Xiao-Long, et al.
Publicado: (2023) -
Clinical significance of microRNA-125b and its contribution to ovarian carcinogenesis
por: Bi, Ya-Nan, et al.
Publicado: (2020) -
Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells
por: Lu, Wei-Qun, et al.
Publicado: (2017)